Dr. Lisa Wu is a clinical psychologist and neuropsychologist with experience in providing neurorehabilitation for individuals with cognitive impairment. Dr. Wu's research is focused on symptom management and quality of life issues in cancer survivors, and the development of interventions to ameliorate such problems. In recent years, Dr. Wu's research has focused primarily on cognitive impairment related to cancer and/or its treatment.
Language
English
Position
ADJUNCT ASSISTANT PROFESSOR | Population Health Science and Policy
About Me
Dr. Lisa Wu is a clinical psychologist and neuropsychologist with experience in providing neurorehabilitation for individuals with cognitive impairment. Dr. Wu's research is focused on symptom management and quality of life issues in cancer survivors, and the development of interventions to ameliorate such problems. In recent years, Dr. Wu's research has focused primarily on cognitive impairment related to cancer and/or its treatment.
Language
English
Position
ADJUNCT ASSISTANT PROFESSOR | Population Health Science and Policy
Education
PhD, Teachers College Columbia University
Research
Dr. Wu has conducted research examining quality of life and survivorship issues in cancer patients, particularly cognitive impairment. In recent years, she has channelled her interest in neurorehabilitation into her research which is primarily focused on the neurobehavioral and neurocognitive changes associated with cancer and its treatment, and the development of interventions to treat such changes. She is also interested in the underlying biological and chronobiological mechanisms of cognitive impairment in cancer survivors. Dr. Wu's research has been funded by the National Cancer Institute and the American Cancer Society.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wu has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Wu has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
